EUROPE’S ANTIVIRAL INNOVATION PLATFORM
Antivirals for today’s viruses and tomorrow’s threats
AVITHRAPID unites academic research and industrial development to get new broad-spectrum antiviral medicines ready – before the next outbreak begins.
BROAD-SPECTRUM ANTIVIRALS
A ZIKA CANDIDATE IN PHASE 2a
A REUSABLE DISCOVERY PIPELINE
Choose your path
A platform for every perspective
Whether you want to understand the threat, follow the science, or build on our results, AVITHRAPID has a path for you.
Protecting your future from the next outbreak
Understand what a pandemic is, how treatments are developed, and why antiviral research matters to you - explained in plain language.
CITIZEN
Track milestones and key discoveries
Follow AVITHRAPID's progress, key results and partnership opportunities - from preclinical breakthroughs to our path toward clinical readiness and exploitation.
INDUSTRY
Accelerate your antiviral R&D
Protocols, compound insights, HPC datasets and AI-driven drug-discovery tools - everything you need to accelerate from target identification to clinical readiness.
RESEARCHER
Three principles guide everything we do
The Strategic Pillars
Scientific Excellence
High-throughput screening and AI-driven drug discovery to identify potent small molecules against WHO-priority pathogens.
Pandemic Preparedness
A 'warm-start' pipeline of ready-to-advance antiviral candidates, so the world can respond fast to future outbreaks.
A LASTING ECOSYSTEM
More than a project: the foundations of a European community of antiviral providers — a shared marketplace of compounds, capabilities and data that keeps responding long after the grant ends.
FEATURED
European Researchers' Night
AVITHRAPID brought broad-spectrum antiviral science to the public.
Latest Updates
